| abstract |
The embodiments disclosed herein relate to compositions for enhancing brain glucose transporters, such as GLUTl and GLUT3, and methods of treating and/or preventing diseases or disorders associated with the regulation GLUTl and GLUT3. Also provided are compositions that include chromium and an agent that targets the brain or the central nervous system. Further provided are improved methods of delivering therapeutic agents that target the brain and/or central nervous system. |